Restoration of p53 function leads to tumour regression in vivoAndrea Ventura, Tyler Jacks, David G. Kirsch et al.|Nature|2007Cited by 1.8k
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Zongyao Wang, O. Alejandro Balbin et al.|Nature Medicine|2015Cited by 1.4k
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974Jun Liu, Jennifer L. Harris, Shifeng Pan et al.|Proceedings of the National Academy of Sciences|2013Cited by 833
Telomerase modulates Wnt signalling by association with target gene chromatinJae‐Il Park, Steven E. Artandi, Andrew S. Venteicher et al.|Nature|2009Cited by 694
In-Depth Characterization and Validation in <i>BRG1</i> -Mutant Lung Cancers Define Novel Catalytic Inhibitors of SWI/SNF Chromatin RemodelingZainab Jagani, Margaret E. McLaughlin, Gregg Chenail et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 9